Bollard Group’s NeoGenomics NEO Stock Holding History

Bollard Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,959	Closed	-$60K	–	362
2022 Q1	$60K	Hold	4,959	–	–	﹤0.01%	327
2021 Q4	$169K	Hold	4,959	–	–	0.01%	248
2021 Q3	$239K	Hold	4,959	–	–	0.01%	213
2021 Q2	$224K	Hold	4,959	–	–	0.01%	216
2021 Q1	$239K	Hold	4,959	–	–	0.01%	202
2020 Q4	$267K	Hold	4,959	–	–	0.01%	181
2020 Q3	$183K	Hold	4,959	–	–	0.01%	198
2020 Q2	$154K	Buy	+4,959	New	+$137K	0.01%	208

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Bollard Group's NEO Position: Q2 2022 in Review

Bollard Group sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 4,959 shares — an estimated $60K sold.

Bollard Group first reported a position in NEO in Q2 2020 and held it in 8 quarters. The position peaked at $267K in Q4 2020. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

Bollard Group reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
Bollard Group sold 4,959 NeoGenomics shares in Q2 2022, an estimated $60K.
Bollard Group first reported a position in NeoGenomics in Q2 2020 and held it in 8 quarters.
Bollard Group's NeoGenomics position peaked at $267K in Q4 2020.
239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.